These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 19594898)

  • 1. Mass spectrometry-based serum proteome pattern analysis in molecular diagnostics of early stage breast cancer.
    Pietrowska M; Marczak L; Polanska J; Behrendt K; Nowicka E; Walaszczyk A; Chmura A; Deja R; Stobiecki M; Polanski A; Tarnawski R; Widlak P
    J Transl Med; 2009 Jul; 7():60. PubMed ID: 19594898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimizing of MALDI-ToF-based low-molecular-weight serum proteome pattern analysis in detection of breast cancer patients; the effect of albumin removal on classification performance.
    Pietrowska M; Marczak L; Polanska J; Nowicka E; Behrent K; Tarnawski R; Stobiecki M; Polanski A; Widlak P
    Neoplasma; 2010; 57(6):537-44. PubMed ID: 20845992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mass spectrometry-based analysis of therapy-related changes in serum proteome patterns of patients with early-stage breast cancer.
    Pietrowska M; Polanska J; Marczak L; Behrendt K; Nowicka E; Stobiecki M; Polanski A; Tarnawski R; Widlak P
    J Transl Med; 2010 Jul; 8():66. PubMed ID: 20618994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomic Profiling of Invasive Ductal Carcinoma (IDC) using Magnetic Beads-based Serum Fractionation and MALDI-TOF MS.
    Yang J; Zhu J; He K; Zhao LY; Liu LY; Song TS; Huang C
    J Clin Lab Anal; 2015 Jul; 29(4):321-7. PubMed ID: 25130542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer.
    Li J; Zhang Z; Rosenzweig J; Wang YY; Chan DW
    Clin Chem; 2002 Aug; 48(8):1296-304. PubMed ID: 12142387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of peptide cancer signatures identified by mass spectrometry in serum of patients with head and neck, lung and colorectal cancers: association with tumor progression.
    Pietrowska M; Polańska J; Suwiński R; Wideł M; Rutkowski T; Marczyk M; Domińczyk I; Ponge L; Marczak L; Polański A; Widłak P
    Int J Oncol; 2012 Jan; 40(1):148-56. PubMed ID: 21894432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential biomarkers for esophageal carcinoma detected by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
    Liu LH; Shan BE; Tian ZQ; Sang MX; Ai J; Zhang ZF; Meng J; Zhu H; Wang SJ
    Clin Chem Lab Med; 2010 Jun; 48(6):855-61. PubMed ID: 20345231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of serum proteome signatures of locally advanced and metastatic gastric cancer: a pilot study.
    Abramowicz A; Wojakowska A; Gdowicz-Klosok A; Polanska J; Rodziewicz P; Polanowski P; Namysl-Kaletka A; Pietrowska M; Wydmanski J; Widlak P
    J Transl Med; 2015 Sep; 13():304. PubMed ID: 26376850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel serum protein biomarker panel revealed by mass spectrometry and its prognostic value in breast cancer.
    Chung L; Moore K; Phillips L; Boyle FM; Marsh DJ; Baxter RC
    Breast Cancer Res; 2014 Jun; 16(3):R63. PubMed ID: 24935269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of early and advanced stages in ovarian cancer using human plasma by differential scanning calorimetry and mass spectrometry.
    Kim NA; Jin JH; Kim KH; Lim DG; Cheong H; Kim YH; Ju W; Kim SC; Jeong SH
    Arch Pharm Res; 2016 May; 39(5):668-76. PubMed ID: 27002828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Detection and clinical significance of serum proteomic patterns of breast cancers by surface enhanced laser desorption/ionization time of flight mass spectrometry].
    Zhang GQ; Du J; Pang D
    Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):204-7. PubMed ID: 16875606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum proteomic biomarker discovery reflective of stage and obesity in breast cancer patients.
    Schaub NP; Jones KJ; Nyalwidhe JO; Cazares LH; Karbassi ID; Semmes OJ; Feliberti EC; Perry RR; Drake RR
    J Am Coll Surg; 2009 May; 208(5):970-8; discussion 978-80. PubMed ID: 19476873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The MALDI-TOF mass spectrometric view of the plasma proteome and peptidome.
    Hortin GL
    Clin Chem; 2006 Jul; 52(7):1223-37. PubMed ID: 16644871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of serum biomarkers for ovarian cancer using MALDI-TOF-MS combined with magnetic beads.
    Wu S; Xu K; Chen G; Zhang J; Liu Z; Xie X
    Int J Clin Oncol; 2012 Apr; 17(2):89-95. PubMed ID: 21638024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construction of a multiple myeloma diagnostic model by magnetic bead-based MALDI-TOF mass spectrometry of serum and pattern recognition software.
    Wang QT; Li YZ; Liang YF; Hu CJ; Zhai YH; Zhao GF; Zhang J; Li N; Ni AP; Chen WM; Xu Y
    Anat Rec (Hoboken); 2009 Apr; 292(4):604-10. PubMed ID: 19301277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of novel serum peptides biomarkers for female breast cancer patients in Western China.
    Yang J; Xiong X; Liu S; Zhu J; Luo M; Liu L; Zhao L; Qin Y; Song T; Huang C
    Proteomics; 2016 Mar; 16(6):925-34. PubMed ID: 26705257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential capture of serum proteins for expression profiling and biomarker discovery in pre- and posttreatment head and neck cancer samples.
    Freed GL; Cazares LH; Fichandler CE; Fuller TW; Sawyer CA; Stack BC; Schraff S; Semmes OJ; Wadsworth JT; Drake RR
    Laryngoscope; 2008 Jan; 118(1):61-8. PubMed ID: 18043497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Highly sensitive detection of melanoma based on serum proteomic profiling.
    Caron J; Mangé A; Guillot B; Solassol J
    J Cancer Res Clin Oncol; 2009 Sep; 135(9):1257-64. PubMed ID: 19288131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-resolution serum proteomic features for ovarian cancer detection.
    Conrads TP; Fusaro VA; Ross S; Johann D; Rajapakse V; Hitt BA; Steinberg SM; Kohn EC; Fishman DA; Whitely G; Barrett JC; Liotta LA; Petricoin EF; Veenstra TD
    Endocr Relat Cancer; 2004 Jun; 11(2):163-78. PubMed ID: 15163296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Search for potential gastric cancer biomarkers using low molecular weight blood plasma proteome profiling by mass spectrometry].
    Shevchenko VE; Arnotskaia NE; Ogorodnikova EV; Davydov MM; Ibraev MA; Turkin IN; Davydov MI
    Biomed Khim; 2014; 60(4):503-14. PubMed ID: 25249535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.